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Abstract Metallothionein (MT), a low molecular weight,
cysteine-rich metal binding protein, has been associated with
cytoprotection from heavy metals and cellular oxidants. As MT
has the ability to scavenge hydroxyl radicals, MT may control
intracellular redox status. In the present study, we examined
whether MT regulates the activity of nuclear factor-UB (NF-UB),
which is one of the redox-regulated transcription factors, using
the MT null embryonic cell lines established from MT null mice.
We first found that tumor necrosis factor (TNF)-induced
activation of the binding of NF-UB protein to DNA in wild type
MT+/+ cells was lower than that in MT3/3 cells. The NF-UB
activation in MT-expressing cells established from MT3/3 cells
by the transfection of mouse MT-I gene was also significantly
lower than that in MT3/3 cells. In addition, transfection of the
MT gene inhibited TNF-induced IUB degradation and suppressed
NF-UB-dependent gene expression induced by TNF. These
results demonstrate that MT may function as a negative
regulator of NF-UB activity.
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1. Introduction
Nuclear factor-UB (NF-UB) is a transcription factor that
regulates a number of cellular genes, such as those encoding
in£ammatory cytokines, adhesion molecules, cyclooxygenase
and nitric oxide synthase [1,2]. In most cell types, NF-UB is
present as a heterodimer comprising p50 and p65 subunits
that is anchored in the cytoplasm by tightly bound inhibitory
protein IUB. Many of the signals known to activate NF-UB
such as tumor necrosis factor (TNF), interleukin-1 and lip-
opolysaccharide result in phosphorylation and subsequent
degradation of IUB, allowing NF-UB to translocate into the
nucleus and activate these target genes. Recent studies indi-
cated that NF-UB activity was regulated by intracellular redox
status and reactive oxygen species (ROS) might be involved in
this NF-UB activation cascade [1^3]. This is based on the
observations that treatment of some cells with H2O2 can acti-
vate NF-UB and that certain antioxidants such as N-acetylcys-
teine or pyrrolidine dithiocarbamate can repress activation of
NF-UB by blocking the signal-induced phosphorylation of
IUB [4]. It was also reported that NF-UB activation was pre-
vented by overexpression of several antioxidant enzymes in-
cluding glutathione peroxidase [5], manganese superoxide dis-
mutase [6,7] and thioredoxin peroxidase [8].
Metallothioneins (MT) are ubiquitous, low molecular
weight, cysteine-rich metal binding proteins [9,10]. Of the
four isoforms of MT, MT-I and MT-II are widely expressed
and coregulated by many agents including metals, hormones,
cytokines and alkylating agents. MT has multiple functions
such as detoxi¢cation of heavy metals including cadmium or
mercury and protection of cells against ROS [10,11]. MT has
been observed in the nucleus and/or cytoplasm of cells [12],
but little is known about its function in the nucleus. As MT
has the ability to scavenge hydroxyl radicals [10], MT may
control intracellular redox status and regulate the activity of
NF-UB and other redox-regulated transcription factors.
Recently, transgenic mice in which the expression of MT-I
and MT-II was disrupted by means of gene targeting were
developed by two groups [13,14]. These mice provided a useful
tool for the investigation of the roles of MT. We very recently
developed a simian virus 40 (SV40)-transformed cell line from
MT null mice [15]. In the present study, we examined whether
MT regulates the NF-UB activity or not using the MT null
embryonic cell lines.
2. Materials and methods
2.1. Cell lines
SV40-transformed embryonic cells from MT null and control mice
(MT3/3 and MT+/+ cells) were prepared as described previously
[15]. Cells were normally maintained in Dulbecco’s modi¢ed Eagle’s
medium (DMEM) containing 10% fetal calf serum (FCS). MT3/3
cells were transfected with pcDNA3.1/Zeo plasmids (Invitrogen,
Carlsbad, CA, USA) by themselves or plasmids containing sense
mouse MT-I (mMT-I) cDNA [16] using the LipofectAMINE method
according to the manufacturer’s instructions (Life Technologies, Inc.,
Rockville, MD, USA). After 48 h, cells were treated with 100 ng/ml of
zeocin. Zeocin-resistant clones were selected and maintained in com-
plete medium supplemented with 100 ng/ml of zeocin.
2.2. Determination of MT
MT levels in the MT null cells and MT-expressing cells were deter-
mined by the Hg binding assay as described previously [17] with some
modi¢cations. Brie£y, 2U105^1U106 cells were harvested with 1.15%
KCl and sonicated. The cell lysate (1.2 ml) was incubated with 10 Wl
of diethylmaleate at room temperature for 15 min. After the addition
of 50 Wl of 10 mM cadmium chloride, the lysate was heated at 100‡C
for 5 min and centrifuged at 1400Ug for 15 min at 4‡C to remove
particles and high molecular weight proteins precipitated. The super-
natant was incubated with 1 nmol HgCl2 to saturate the metal bind-
ing sites of MT by Hg. Excess Hg was removed by the addition of
ovalbumin (30 pmol) followed by acidi¢cation with 50 Wl of 100%
trichloroacetic acid solution and subsequent centrifugation at
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1800Ug for 25 min at 15‡C. The supernatant was collected and the
amount of Hg was measured by cold vapor £ameless atomic absorp-
tion spectroscopy and expressed as pmol Hg bound to MT.
2.3. Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared from TNF- or H2O2-treated cells as
described previously [18] and incubated with 32P-labeled 22-mer dou-
ble-stranded NF-UB oligonucleotide (5P-AGTTGAGGGGACTTT-
CCCAGGC-3P) for 30 min at room temperature. Native 4% poly-
acrylamide gels were used to analyze the samples. A double-
stranded mutated oligonucleotide (5P-AGTTGAGatcactggga-
CAGGC-3P) was used to examine the speci¢city of binding of NF-
UB to the DNA. The speci¢city of binding was also examined by
competition with the unlabeled oligonucleotide. Antibodies against
p65 and p50 for supershift analysis were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). The dried gels were visualized
and radioactive bands were quantitated by a Fujix Bio-Imaging ana-
lyzer BAS 2000 (Fuji Photo Film Co., Tokyo, Japan).
2.4. Transient transfection and luciferase assay
Mock-transfected Zeo cells and mMT-I-transfected cells were tran-
siently transfected with UB site-driven luciferase reporter (3UUB-Luc)
by the LipofectAMINE method. 3UUB-Luc was a kind gift from Dr.
Shigeki Miyamoto and contains the luciferase gene under the control
of herpes simplex thymidine kinase promoter with three NF-UB bind-
ing sites. Six hours after transfection, the cells were cultured for 24 h
at 37‡C, stimulated with TNF for 6 h in 0.5% FCS-containing
DMEM and examined for luciferase activity as described previously
[19].
2.5. Western blot analysis
Total cell extracts were prepared from TNF-treated cells and loaded
on 12% SDS-polyacrylamide gels. After electrophoresis, the proteins
were electrotransferred to polyvinylidene di£uoride membranes,
probed with rabbit polyclonal antibodies against IUB (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), and detected by chemilumi-
nescence (ECL, Amersham, Buckinghamshire, UK).
3. Results and discussion
3.1. Expression of MT inhibits TNF-induced NF-UB activation
We ¢rst examined binding activity of nuclear NF-UB to
DNA in MT null cells and wild type cells (MT3/3 and
MT+/+ cells, respectively) by EMSA. Most studies on the
function of MT had utilized MT inducers such as Zn com-
pounds to increase the level of MT, but other e¡ects of the
inducing compounds than MT induction could not be elimi-
nated by this approach. In fact, many kinds of MT inducers
including Zn a¡ect gene transcription and translation [20] and
it had been di⁄cult to examine the e¡ects of MT itself on gene
expression by using MT inducers. In the present study, using
the MT null cells, we could examine the e¡ect of MT on NF-
UB activation without using MT inducers.
When MT3/3 and MT+/+ cells were stimulated with dif-
ferent concentrations of TNF, NF-UB binding activities in
nuclear extracts prepared from both cells increased in a
dose-dependent manner. Although the basal level of DNA
binding activity in MT3/3 cells was lower than that in
MT+/+ cells, the binding activity in MT3/3 cells treated
with TNF was higher than that in MT+/+ cells (Fig. 1A).
Speci¢city of binding was con¢rmed by the observation that
this binding was competed with unlabeled wild type probe but
not with the probe having a mutated NF-UB binding site (Fig.
1B). Since antibodies against the p50 and p65 subunits of NF-
UB supershifted the band on the gel shift (Fig. 1C), NF-UB
activated by TNF consisted of p50 and p65 subunits.
We next tried to establish MT-expressing cells from MT3/
3 cells by the transfection with the plasmid containing mMT-
I cDNA. After the selection with zeocin, we established sev-
eral clones and measured MT levels in these clones by the Hg
binding method as described in Section 2. The MT levels of
parental MT3/3 cells determined by this method might be
due to low molecular weight Hg binding proteins other than
MT. Among the Zeo-resistant clones, M1 and M4 cells ex-
Fig. 1. E¡ect of expression of MT gene on TNF-dependent activa-
tion of NF-UB. A: MT+/+ cells and MT3/3 cells were incubated
at 37‡C with di¡erent concentrations of TNF for 30 min, and then
nuclear extracts were prepared and assayed for NF-UB binding ac-
tivities by EMSA. Relative DNA binding activity was calculated as
the ratio of the radioactivity of the NF-UB site binding band to
that in non-treated MT+/+ cells. B and C: Nuclear extracts were
prepared from untreated or TNF-treated MT3/3 cells, incubated
for 30 min with cold wild type (wt-oligo) or mutant (mut-oligo)
NF-UB oligo probes (B) and rabbit preimmune serum (PIS) or anti-
p65 or p50 antibodies (C), and then assayed for NF-UB binding ac-
tivities.
Table 1
MT levels in MT+/+, MT3/3 and MT3/3-derived cell lines
MT level (pmol Hg/mg protein)
MT+/+ cells 22.1 þ 3.5
MT3/3 cells 7.0 þ 0.7
Mock-transfected Zeo cells 7.7 þ 2.7
mMT-I-transfected M1 cells 11.9 þ 3.1
mMT-I-transfected M4 cells 12.3 þ 4.0
MT levels were determined by the modi¢ed Hg binding assay as de-
scribed in Section 2.
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pressed signi¢cantly higher levels of MT than parental MT3/
3 cells (Table 1). On the other hand, the MT levels of mock-
transfected Zeo cells were almost equivalent to that of the
parental cells.
Mock-transfected Zeo cells and mMT-I-transfected M1 and
M4 cells were stimulated with TNF and the DNA binding
activities were examined by EMSA. As shown in Fig. 2,
TNF activated NF-UB in Zeo cells as well as non-transfected
MT3/3 cells, whereas in both M1 and M4 cells, NF-UB ac-
tivation was signi¢cantly suppressed. The binding activity of
NF-UB stimulated by H2O2 was also suppressed in MT-trans-
fected cells (data not shown). These results thus indicated that
expression of MT inhibited NF-UB activation, suggesting that
MT might function as a negative regulator of NF-UB.
3.2. Expression of MT suppresses NF-UB-dependent reporter
gene expression induced by TNF
We next examined whether expression of MT suppresses
NF-UB-dependent gene expression or not. NF-UB-dependent
luciferase reporter gene was transiently transfected into Zeo
cells and mMT-I-transfected M1 and M4 cells, and then the
cells were stimulated with TNF. We ¢rst treated the cells with
10 ng/ml of TNF for 30 min, 2 h and 6 h, but TNF-induced
increment of luciferase activity was not observed in these MT
null mice-derived SV40-transformed embryonic cells. Thus,
we stimulated the reporter gene-transfected cells with 50 ng/
ml of TNF for 6 h. As shown in Fig. 3, 50 ng/ml of TNF
activated luciferase activity by about 1.5-fold in Zeo cells. On
the other hand, no increase in luciferase activity over the basal
level was observed in both M1 and M4 cells. These results
suggested that the expression of MT suppressed TNF-induced
NF-UB-dependent gene expression. Very recently, Abdel-Ma-
geed et al. reported that transfection with human MT-II
cDNA into MCF-7 cells caused transactivation of NF-UB
[21]. However, we could not observe di¡erences of luciferase
activities between Zeo cells and mMT-I-transfected cells with-
out the treatment of TNF.
3.3. MT inhibits TNF-dependent degradation of IUB
Association with the inhibitory IUB proteins tightly regu-
lates the activity of NF-UB. Activation of NF-UB is triggered
by signal-dependent phosphorylation and subsequent degra-
dation of IUB through the activation of IUB kinase [1^3]. The
observations that both treatment of antioxidants and overex-
pression of antioxidant enzymes [5,6] inhibited IUB degrada-
tion indicated the involvement of ROS in the signal-induced
IUB kinase activation [2]. To determine whether MT also in-
hibits TNF-induced IUB degradation as an antioxidant, the
levels of cellular IUB proteins after treatment of cells with
TNF for di¡erent time periods were examined by Western
blot analysis. IUB was degraded after 20^30 min of treatment
with TNF, and then retranscribed as a result of NF-UB acti-
Fig. 2. E¡ect of transfection with mMT-I expression vector on
TNF-dependent activation of NF-UB. Mock-transfected Zeo cells
and mMT-I-transfected M1 and M4 cells were incubated at 37‡C
with di¡erent concentrations of TNF for 30 min and then nuclear
extracts were prepared and assayed for NF-UB binding activities by
EMSA. Relative DNA binding activity was calculated as the ratio
of the radioactivity of the NF-UB site binding band to that in non-
treated Zeo cells.
Fig. 3. E¡ect of transfection with mMT-I expression vector on NF-
UB-dependent luciferase reporter gene expression. Mock-transfected
Zeo cells (open column) and mMT-I-transfected M1 (shaded col-
umn) and M4 cells (closed column) were transiently transfected with
3UUB-Luc reporter gene, treated with 50 ng/ml of TNF for 6 h,
and then assayed for luciferase activities. *P6 0.05 and **P6 0.01
vs. Zeo cells by t-test.
Fig. 4. E¡ect of transfection with mMT-I expression vector on
TNF-induced degradation of IUBK. Mock-transfected Zeo cells or
mMT-I-transfected M4 cells were incubated for di¡erent time peri-
ods with TNF (10 ng/ml) and then assayed for IUBK in cell lysates
by Western blot analysis.
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vation and reappeared at 60 min in Zeo cells (Fig. 4). In
mMT-I-transfected M4 cells, however, a lesser extent of IUB
degradation was observed in response to TNF. These results
suggested that MT, as well as other antioxidants, might reg-
ulate IUB degradation through its ability to scavenge ROS in
the cytoplasm of cells.
MT has been observed in both the nucleus and cytoplasm
[12], but little is known about its function in the nucleus.
Although we have shown that MT suppresses TNF-induced
NF-UB activation by the inhibition of IUB degradation in the
cytoplasm, the possibility still remains that MT may regulate
NF-UB activity in the nucleus. It was recently shown that MT
directly interacted with NF-UB by EMSA supershift analysis
using anti-MT antibody [21], although we could not observe
an interaction between NF-UB and MT when we used com-
mercial anti-MT antibody (data not shown). MT has an abil-
ity to bind Zn and regulate Zn homeostasis in the cells [9] and
Zn is an essential component of NF-UB for its DNA binding
activity [22]. It was also reported that apoMT could remove
Zn from Zn ¢nger containing factors Sp1 and TFIIIA and
modulate their activities to bind to DNA and RNA [23,24].
In summary, using MT null cells, we found that MT may
function as a negative regulator of NF-UB activity. It was
suggested that MT might suppress NF-UB-dependent gene
expression through the inhibition of IUB degradation. How-
ever, further study is needed to clarify the precise mechanism
by which MT regulates NF-UB activity.
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